HomeCompareUELKY vs VIG

UELKY vs VIG: Dividend Comparison 2026

UELKY yields 7.64% · VIG yields 1.61%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 UELKY wins by $76690.14M in total portfolio value
10 years
UELKY
UELKY
● Live price
7.64%
Share price
$27.00
Annual div
$2.06
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$76690.17M
Annual income
$74,808,536,165.81
Full UELKY calculator →
VIG
Vanguard Dividend Appreciation ETF
● Live price
1.61%
Share price
$215.06
Annual div
$3.45
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$32.3K
Annual income
$175.21
Full VIG calculator →

Portfolio growth — UELKY vs VIG

📍 UELKY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodUELKYVIG
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, UELKY + VIG cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
UELKY pays
VIG pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

UELKY
Annual income on $10K today (after 15% tax)
$649.19/yr
After 10yr DRIP, annual income (after tax)
$63,587,255,740.94/yr
VIG
Annual income on $10K today (after 15% tax)
$136.50/yr
After 10yr DRIP, annual income (after tax)
$148.93/yr
At 15% tax rate, UELKY beats the other by $63,587,255,592.01/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of UELKY + VIG for your $10,000?

UELKY: 50%VIG: 50%
100% VIG50/50100% UELKY
Portfolio after 10yr
$38345.10M
Annual income
$37,404,268,170.50/yr
Blended yield
97.55%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on VIG right now

UELKY
Analyst Ratings
1
Sell
Consensus: Sell
Altman Z
2.3
Piotroski
5/9
VIG
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

UELKY buys
0
VIG buys
9
PoliticianChamberTickerTypeAmountDate
Thomas R. Carper🏛 Senate$VIG▲ Buy$1,001 - $15,0002024-05-16
Lindsey Graham🏛 Senate$VIG▼ Sell$15,001 - $50,0002024-01-26
Lindsey Graham🏛 Senate$VIG▼ Sell$15,001 - $50,0002024-01-26
Lindsey Graham🏛 Senate$VIG▼ Sell$15,001 - $50,0002023-12-28
Ro Khanna🏢 House$VIG▼ Sell$15,001 - $50,0002023-05-04
K. Michael Conaway🏢 House$VIG▲ Buy$50,001 - $100,0002020-12-10
K. Michael Conaway🏢 House$VIG▲ Buy$50,001 - $100,0002020-12-10
Joe Courtney🏢 House$VIG▼ Sell$1,001 - $15,0002020-10-09
K. Michael Conaway🏢 House$VIG▼ Sell$50,001 - $100,0002020-09-08
K. Michael Conaway🏢 House$VIG▲ Buy$15,001 - $50,0002020-05-19
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricUELKYVIG
Forward yield7.64%1.61%
Annual dividend / share$2.06$3.45
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%0%
Portfolio after 10y$76690.17M$32.3K
Annual income after 10y$74,808,536,165.81$175.21
Total dividends collected$76561.43M$1.7K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: UELKY vs VIG ($10,000, DRIP)

YearUELKY PortfolioUELKY Income/yrVIG PortfolioVIG Income/yrGap
1← crossover$12,228$1,527.51$11,301$160.59+$927.00UELKY
2$16,575$3,491.15$12,752$162.91+$3.8KUELKY
3$26,580$8,845.44$14,370$165.02+$12.2KUELKY
4$54,955$26,514.42$16,176$166.93+$38.8KUELKY
5$161,268$102,465.75$18,188$168.67+$143.1KUELKY
6$734,592$562,035.10$20,432$170.25+$714.2KUELKY
7$5,571,297$4,785,284.25$22,933$171.68+$5.55MUELKY
8$73,797,916$67,836,627.45$25,720$172.98+$73.77MUELKY
9$1,758,534,192$1,679,570,421.98$28,827$174.15+$1758.51MUELKY
10$76,690,167,751$74,808,536,165.81$32,288$175.21+$76690.14MUELKY

UELKY vs VIG: Complete Analysis 2026

UELKYStock

Ülker Bisküvi Sanayi A.S., together with its subsidiaries, engages in the manufacture, marketing, and sale of biscuits, chocolates, chocolate coated biscuits, cakes, wafers, and crackers in Turkey and internationally. The company also produces chocolate dough, cocoa powder, chocolate drop, chocolate flakes, couverture chocolate, flour, hazelnut, and pureed hazelnut. In addition, it is also involved in the trading and investment activities. The company offers its products under the various company owned brands, as well as private labels. It also exports its products to the Middle East, Russia, Central Asian republics, Europe, Africa, and the United States. The company was founded in 1944 and is headquartered in Istanbul, Turkey. Ülker Bisküvi Sanayi A.S. is a subsidiary of pladis Foods Limited.

Full UELKY Calculator →

VIGETF

Seeks to track the performance of the S&P U.S. Dividend Growers Index.Passively managed, full-replication approach.Fund remains fully invested.Large-cap equity, emphasizing stocks with a record of growing their dividends year over year.Low expenses minimize net tracking error.With respect to 75% of its total assets, the fund may not: (1) purchase more than 10% of the outstanding voting securities of any one issuer or (2) purchase securities of any issuer if, as a result, more than 5% of the fund’s total assets would be invested in that issuer’s securities; except as may be necessary to approximate the composition of its target index. This limitation does not apply to obligations of the U.S. government or its agencies or instrumentalities.

Full VIG Calculator →
📬

Get this UELKY vs VIG comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

UELKY vs SCHDUELKY vs JEPIUELKY vs OUELKY vs KOUELKY vs MAINUELKY vs DGROUELKY vs NOBLUELKY vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.